Literature DB >> 20617896

Ischemia-modified albumin as an oxidative stress marker in preeclampsia.

Yusuf Ustün1, Yaprak Engin-Ustün, Ozlem Oztürk, Ibrahim Alanbay, Halil Yaman.   

Abstract

OBJECTIVE: We examined serum ischaemia-modified albumin (IMA) levels in normal pregnant and preeclamptic women. The primary aim of our study was to assess IMA in women with mild and severe preeclampsia.
METHODS: Serum ischaemia-modified albumin levels were measured in 18 normotensive and 36 preeclamptic pregnant women by enzyme linked immuno-sorbent assay. Patients were subdivided as having either mild (n=18) or severe preeclampsia (n=18). Receiver operating characteristic curve was constructed, and sensitivity and specificity were calculated based on the best cut-off.
RESULTS: IMA levels were significantly higher in the mild and severe preeclamptic groups than in the control group. IMA with a cut-off point of 0.31 identified women with preeclampsia with sensitivity 80% and specificity 77.8%.
CONCLUSION: Our study demonstrates that serum levels of IMA correlate with severity of preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20617896     DOI: 10.3109/14767058.2010.497879

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  9 in total

1.  Serum Ischemia-Modified Albumin in Preterm Babies with Respiratory Distress Syndrome.

Authors:  Hasan Kahveci; Cuneyt Tayman; Fuat Laoğlu; Hüseyin Tugrul Celik; Nazan Kavas; Ömer Kılıç; Salih Aydemir
Journal:  Indian J Clin Biochem       Date:  2015-04-28

2.  Association of Maternal Serum Ischemia Modified Albumin (IMA) with Placental Histopathological Changes and Fetomaternal Outcome: A Prospective Case Control Study in Normotensive and Pre-eclamptic Women.

Authors:  Shyam Pyari Jaiswar; Shikha Verma; Monica Agrawal; Sujata Deo; Madhumati Goel; Abbas Ali Mahdi
Journal:  J Obstet Gynaecol India       Date:  2022-02-12

3.  The relationship between oxidative stress and preeclampsia. The serum ischemia-modified albumin levels and thiol/disulfide homeostasis.

Authors:  Taylan Onat; Demet Aydoğan Kırmızı; Emre Başer; Müjgan Ercan; Melike Demir Çaltekin; Serenat Yalçın; Mustafa Kara; Deniz Esinler; Ethem Serdar Yalvaç
Journal:  Turk J Obstet Gynecol       Date:  2020-07-29

4.  The diagnostic potential of oxidative stress biomarkers for preeclampsia: systematic review and meta-analysis.

Authors:  Dinara Afrose; Hao Chen; Amali Ranashinghe; Chia-Chi Liu; Annemarie Henessy; Philip M Hansbro; Lana McClements
Journal:  Biol Sex Differ       Date:  2022-06-04       Impact factor: 8.811

5.  Relationship Between Hemodynamically Significant Ductus Arteriosus and Ischemia-Modified Albumin in Premature Infants.

Authors:  Hasan Kahveci; Cüneyt Tayman; Fuat Laloğlu; Nazan Kavas; Murat Ciftel; Osman Yılmaz; Esra Laloğlu; Abdulah Erdil; Hülya Aksoy; Salih Aydemir
Journal:  Indian J Clin Biochem       Date:  2015-09-15

6.  Maternal serum ischemia modified albumin as a marker for hypertensive disorders of pregnancy: a pilot study.

Authors:  Sapna Vyakaranam; Aparna Varma Bhongir; Dakshayani Patlolla; Rekha Chintapally
Journal:  Int J Reprod Contracept Obstet Gynecol       Date:  2015-06

7.  Ischemia-Modified Albumin, Creatinine, And Paraoxonase-1 Levels in Serum of Patients Undergoing Intravenous Contrast-Enhanced Computed Tomography and Its Association with Contrast-Induced Nephropathy.

Authors:  Chanda Jha; Shobha Ullas Kamath; Sambit Dash; Ravindra Prabhu Attur; Lingadakai Ramachandra; Rajgopal Shenoy Kallya
Journal:  Rep Biochem Mol Biol       Date:  2019-04

8.  The Diagnostic Value of β-Human Chorionic Gonadotropin, Progesterone, and Ischemia-Modified Albumin and Their Combined Use in the Prediction of First Trimester Abortions.

Authors:  Mehmet A Osmanağaoğlu; S Caner Karahan; Turhan Aran; Süleyman Güven; Elif Turgut; Ahmet Menteşe; Hasan Bozkaya
Journal:  Int Sch Res Notices       Date:  2014-07-01

9.  Could first- and second-trimester biochemical markers for Down syndrome have a role in predicting intrahepatic cholestasis of pregnancy?

Authors:  Ahter Tanay Tayyar; Ahmet Tayyar; Tolga Atakul; Cigdem Abide Yayla; Cetin Kilicci; Ahmet Eser; Resul Karakus; Dilsat Herkiloglu; Cevat Rifat Cundubey; Mehmet Tayyar
Journal:  Arch Med Sci       Date:  2017-09-05       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.